HCPCS Level II · Drugs administered other than oral method
J7297Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7297
J7297 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg.
It was added to HCPCS effective 01/01/2016, and its current record took effect 01/01/2017.
Its Medicare coverage code is "S", meaning it is not covered by Medicare by statute.
Details
- Short description
- Liletta, 52 mg
- Date added
- 01/01/2016
- Action effective
- 01/01/2017
- BETOS
- P6C
Related J72xx codes
- J7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu
- J7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.
- J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.
- J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
- J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu
- J7205Injection, factor viii fc fusion protein (recombinant), per iu
- J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.
- J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
- J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.
- J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
- J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
- J7212Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram
Common questions about J7297
Is HCPCS J7297 still valid?
- Yes. J7297 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J7297?
- Its coverage code is "S": it is not covered by Medicare by statute. Check the local coverage determination for your region.